Grace Colón

Biotechnology CEO, Board Member and Entrepreneur | Championing Underrepresented Groups In the Boardroom, C-Suite, and Everywhere | Speaker | Connector | Mentor | Women's Health Advocate | LatinX/Latine | Mom

Grace Colón, who serves as the Chair of the Board of Directors at Bloom Science, Inc., is a highly experienced executive and board member in the biotechnology and life sciences industry. Here are some key points about her background and experience:

Education

She holds a B.S.E. from the University of Pennsylvania (1984-1988) and a Ph.D. from the Massachusetts Institute of Technology (MIT) in Biology (1989-1995).1

Professional Experience

Colón has held various senior roles, including:
- President and CEO of ProterixBio, Inc. (February 2015 - October 2016).1
- President, CEO, and Director of InCarda Therapeutics (March 2013 - September 2022).1
- Senior positions at Gilead Sciences, such as Head of Clinical Operations, Head of Alliance Management, and Senior Director of Corporate Strategy (2005-2010).1
- Vice President of Corporate Planning at Affymetrix (August 2000 - January 2005).1
- Engagement Manager at McKinsey & Company (August 1996 - August 2000).1

Current Roles

Chair, Board of Directors at Bloom Science, Inc. (May 2023 - Present).1
Board Member at Voyager Therapeutics, Inc. (January 2023 - Present).1
Board Member at CareDx, Inc. (July 2019 - Present).1
Board Member at Biotechnology Innovation Organization (June 2021 - Present).1
Executive Chair, Board of Directors at ProterixBio, Inc. (November 2016 - Present).1
Strategic Advisor at Starling Biosciences, Inc. (December 2022 - Present) and Advisor at InCarda Therapeutics (October 2022 - Present).1

Other Affiliations

Board Member of the MIT Corporation (July 2021 - Present).1
Advisory Board Member and Mentor at the Miller Center for Social Entrepreneurship, Santa Clara University (February 2014 - December 2020).1

Languages

She has native or bilingual proficiency in English and Spanish, full professional proficiency in French, and limited working proficiency in Italian.1

Grace Colón's extensive experience in the biotechnology sector, combined with her leadership roles in various companies, makes her a significant figure in the industry.